Johnson & Johnson Fined for Bribing Doctors
JUSTICE, 11 Apr 2011
Agence France-Presse – The Raw Story
US authorities fined cosmetics and drugs giant Johnson & Johnson $70 million on Friday [8 Mar 2011] for bribing doctors in Europe and paying kickbacks for contracts under a UN relief program in Iraq.
The Department of Justice and Securities and Exchange Commission said since 1998 the firm had paid doctors and hospital administrators in Greece, Poland and Romania for contracts and to promote its drugs and medical devices.
Johnson & Johnson also paid kickbacks between 2000-2003 for 19 contracts under the UN Oil for Food Program, which provided humanitarian supplies to Iraqis while the country, still ruled by Saddam Hussein.
The firm, the 15th largest US company by market capitalization, agreed to pay US authorities $70 million to settle the charges, including $48.6 million to the SEC and $21.4 million to the Justice Department.
US prosecutor Mythili Raman that the company had “cooperated extensively” with the investigation.
“The message … is plain — any competitive advantage gained through corruption is a mirage,” said SEC enforcement director Robert Khuzami.
“J&J chose profit margins over compliance with the law by acquiring a private company for the purpose of paying bribes, and using sham contracts, offshore companies, and slush funds to cover its tracks.”
The charges detailed that J&J subsidiaries Cilag AG International and Janssen Pharaceutica made $858,000 dollars in payoffs to Saddam Hussein’s government to win $9.0 million in contracts under the deeply corrupted Oil for Food Program.
“The kickbacks were concealed from the United Nations by inflating Janssen and Cilag’s contract prices by 10 percent,” they said.
The SEC said J&J was under a related investigation by Britain’s Serious Fraud Office and that a resolution was also expected.
DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.